Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 2176 AL 2190

From protocol to product: ventral midbrain dopaminergic neuron differentiation for the treatment of Parkinson's disease

Kusena JW, Thomas RJ, McCall MJ, Wilson SL.

Regen Med. 2019 Nov;14(11):1057-1069. doi: 10.2217/rme-2019-0076. Epub 2019 Nov 13.

The EXPANd trial: effects of exercise and exploring neuroplastic changes in people with Parkinson's disease: a study protocol for a double-blinded randomized controlled trial

Franzén E, Johansson H, Freidle M, Ekman U, Wallén MB, Schalling E, Lebedev A, Lövdén M, Holmin S, Svenningsson P, Hagströmer M.

BMC Neurol. 2019 Nov 12;19(1):280. doi: 10.1186/s12883-019-1520-2.

[Influence of methodological changes on unicausal cause-of-death statistics and potentials of a multicausal data basis]

Buschner A, Grunwald-Mühlberger A.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Dec;62(12):1476-1484. doi: 10.1007/s00103-019-03048-z.

Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition

Krajcovicova L, Klobusiakova P, Rektorova I.

Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):85. doi: 10.1007/s11910-019-1006-z.

The potential role of necroptosis in inflammaging and aging

Royce GH, Brown-Borg HM, Deepa SS.

Geroscience. 2019 Dec;41(6):795-811. doi: 10.1007/s11357-019-00131-w. Epub 2019 Nov 13.

Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets

Gambino CM, Sasso BL, Bivona G, Agnello L, Ciaccio M.

Curr Pharm Des. 2019;25(39):4168-4174. doi: 10.2174/1381612825666191112093034.

Neurobehavioral Consequences Associated with Long Term Tramadol Utilization and Pathological Mechanisms

Raj K, Chawla P, Singh S.

CNS Neurol Disord Drug Targets. 2019;18(10):758-768. doi: 10.2174/1871527318666191112124435.

Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease

Hertel J, Harms AC, Heinken A, Baldini F, Thinnes CC, Glaab E, Vasco DA, Pietzner M, Stewart ID, Wareham NJ, Langenberg C, Trenkwalder C, Krüger R, Hankemeier T, Fleming RMT, Mollenhauer B, Thiele I.

Cell Rep. 2019 Nov 12;29(7):1767-1777.e8. doi: 10.1016/j.celrep.2019.10.035.

[The Current State of Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex in the Kii Peninsula, Japan, 2019]

Kokubo Y.

Brain Nerve. 2019 Nov;71(11):1236-1244. doi: 10.11477/mf.1416201433.

Neurotoxic and Neuroprotective Role of Exosomes in Parkinson's Disease

Longoni B, Fasciani I, Kolachalam S, Pietrantoni I, Marampon F, Petragnano F, Aloisi G, Coppolino MF, Rossi M, Scarselli M, Maggio R.

Curr Pharm Des. 2019;25(42):4510-4522. doi: 10.2174/1381612825666191113103537.

Correction to: Does transcranial direct current stimulation improve functional locomotion in people with Parkinson's disease? A systematic review and meta-analysis

Lee HK, Ahn SJ, Shin YM, Kang N, Cauraugh JH.

J Neuroeng Rehabil. 2019 Nov 14;16(1):139. doi: 10.1186/s12984-019-0582-0.

Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration

Fabbrini G, Fabbrini A, Suppa A.

Handb Clin Neurol. 2019;165:155-177. doi: 10.1016/B978-0-444-64012-3.00009-5.

The psychopharmacology of pseudobulbar affect

Nguyen L, Matsumoto RR.

Handb Clin Neurol. 2019;165:243-251. doi: 10.1016/B978-0-444-64012-3.00014-9.

Behavioral symptomatology and psychopharmacology of Lewy body dementia

Tampi RR, Young JJ, Tampi D.

Handb Clin Neurol. 2019;165:59-70. doi: 10.1016/B978-0-444-64012-3.00005-8.

Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics

Butala A, Shepard M, Pontone G.

Handb Clin Neurol. 2019;165:83-121. doi: 10.1016/B978-0-444-64012-3.00007-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias